Pancreatic Cancer Research

ResearcherSun Yat-sen UniversityActive in the last 2 years

Xiao Feng Wu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-7895-8460; OpenAlex author ID A5058620963. Sources: OpenAlex.

Their work

Papers
4
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2022: 2 papers · 2023: 1 paper · 2024: none · 2025: none · 2026: 1 paper

Papers 4

  1. CREB-SEC61G feedback loop sustains enhanced autophagy and boosts proliferation in PDAC. Co-author DOI 10.1038/s41419-026-08915-7↗
  2. SUMO specific peptidase 3 halts pancreatic ductal adenocarcinoma metastasis via deSUMOylating DKC1. Co-author DOI 10.1038/s41418-023-01175-4↗
  3. ACLP promotes activation of cancer-associated fibroblasts and tumor metastasis via ACLP-PPARγ-ACLP feedback loop in pancreatic cancer. Co-author DOI 10.1016/j.canlet.2022.215802↗
  4. Pancreatic ductal adenocarcinoma cells regulated the gemcitabine-resistance function of CAFs by LINC00460. Co-author DOI 10.1111/cas.15547↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Xuhao Ni · 4 shared papers, 2022–2026 · strength 0.78
  2. Ya-Xiong Li · 3 shared papers, 2022–2023 · strength 0.50
  3. Xiao‐Xu Zhu · 3 shared papers, 2022–2023 · strength 0.50
  4. Wei Zhao · 2 shared papers, 2022–2023 · strength 0.34
  5. Xiao-Yu Yin · 2 shared papers, 2022–2023 · strength 0.34
  6. Xiaoyu Yin · 1 shared paper, 2022 · strength 0.16

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.